Business
Investment in mLED Limited
Investment in mLED Limited.
About this update from Truetide Plc
[{"type":"text","content":"\n RNS Number : 6835O Braveheart Investment Group plc 02 July 2010 \n \n\n2 July 2010\n \nBraveheart Investment Group plc\n(\"Braveheart\" or the \"Group\")\n \nInvestment in mLED limited\n \nBraveheart (AIM: BRH), the technology commercialisation and investment management company, today announces an investment into mLED Limited (\"mLED\" or \"the Company\"), a spin-out from the University of Strathclyde (\"Strathclyde\" or \"the University\"). The £150,000 funding package comprises funds from Braveheart's Strathclyde Innovation Fund and its Alpha Fund, as well as from Scottish Enterprise's Seed Fund.\n \nmLED is a newly formed company, which has developed its technology at the University's Institute of Photonics (\"IoP\"). The IoP is recognised as a world leading institute in the development and supply of micro light emitting diodes (\"microLEDs\"). \n \nmicroLEDs are devices made up of thousands of tiny emitters producing light in a compact, integrated package. Unlike other micro-display technologies, microLEDs do not require a plethora of external components, such as optics and switching matrices, to modulate the light pattern, thereby making them more compact and efficient and ideal for miniature applications. \n \nThe IoP and its work has generated enquiries from academic and industrial bodies on availability of microLED devices for a range of applications including optogenetic studies. Optogenetics is a relatively new body of research in neuroscience and is being used in order to gain an understanding of how the brain processes information in order to precisely identify circuitry implicated in neurodegenerative disorders. It is anticipated that optogenetic tools and the resultant findings will revolutionise medical science and could impact on future treatments for conditions such as Alzheimer's, Parkinson's, depression and chronic pain. The Company is planning on initially addressing the neurotechnology market which, is forecast to grow from US$3.6 billion in 2008 to US$8.8 billion in 2012/13. \n \nOther applicable market sectors include micro-displays, wireless communications, microscopy, pico projection, general lighting, printing and photolithography.\n \nCommenting on the investment, Geoffrey Thomson, Chief Executive of Bravehear...